echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Brit J Cancer: Taking metformin in patients with gastric adenocarcinoma can improve the prognosis

    Brit J Cancer: Taking metformin in patients with gastric adenocarcinoma can improve the prognosis

    • Last Update: 2021-05-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Receiving metformin treatment may improve the prognosis of patients with gastric adenocarcinoma, but the amount of existing literature is very limited and the results are conflicting.


    Metformin

    Recently, a research article was published in the British Journal of Cancer, an authoritative journal in the field of oncology.


    Diagnose diabetes

    The data for the study comes from four national health data registries: the prescription drug registry, the cancer registry, the patient registry, and the cause of death registry.


    Cumulative mortality curve of metformin users and non-users

    Through analysis, the researchers found that compared with non-metformin users, the disease-specific mortality (HR 0.



    Metformin can improve the survival rate of diabetic patients with gastric adenocarcinoma

    Original source:

    Original source:

    Jiaojiao Zheng.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.